I would think the sooner this can be resolved the
Post# of 11802
Grasshopper, much has been made already about the Lifescan sale hold-back where somewhere around $200 million was held back (10%) for settlement of contingent liabilities. I would guess that J&J would be given a certain amount of time post-sale to settle these liabilities and thus be able to keep the monies from the hold-back, or at least part of them. But after a certain point in time those monies would become the responsibility of Platinum because after all it is their money and now their contingent liability. So, if I were a lower level legal manager at Platinum I would view any settlement with DECN as if I were spending J&J's money and who is going to stop me. My personal belief is that J&J moved on from all of this a micro-second after the closure of the sale of Lifescan.
Now, KB has thrown a monkey wrench into all of this by redesigning an upcoming DECN product that will primarily serve one business goal and one business model -- while making a settlement less acrimonious, easier and worthwhile.
But Grasshopper, it is still all and only about DECN share price and after any settlement the distribution of the spoils to long suffering (LOLOL) penny traders. The strategy of running the DECN business doesn't really matter any longer, if it ever really did. And who cares anyway, iHub posters are going to send Mr. Berman to jail and we are all going to lose our investments in DECN.